INVO BioScience Inc (INVO) Quote

INVO is simply a re-cap merger. Controlled shares won’t convert for 300 plus days and that’s a big laugh. They will surely do another merger which will cancel out any existing plans. ESHA will be a great deal coming up which should help Cytovia and its controlled sub Naya. INVO is non existent now. We gobbled it up. Everyone got their share interests. That defunct drug fund guy got into Naya on the ground floor. I still get my percentage. Laughing until the end. Onto the next target. Cuckoo Penny

Don’t forget folk that controlled sub Cytovia is still under BK.
“M&A activity happens when companies want to expend, unite efforts, move into new segments, or maximize stakeholder value. After the transaction is complete, new shares are distributed to the shareholders of both merging companies. An exchange offer usually happens in bankruptcy cases, when a firm or financial entity exchanges securities for similar ones at less rigid terms.“

So glad they made withdrawal. Great sign. Perfect sign. Choo Choo Cuckoo Penny

A few million shares. Nothing happening until delisting and deregistered. Maybe they get a financing. Don’t need to since they have creditors providing monthly payments. They are now clear sailing from here on out. I think they are going to be rolled up. Easy Peasy Lemon Squeezy. Best to you guys. Stay you.

Nice thing here folks is that Naya Bioscience is focused on trials for the next few years. They will receive their financing each month building their leverage. They have their creditors slowly building their interests in the company. It’s a nice wash. No new shares so same old story. They will just build that debt until time is right for creditors to convert. There is no rush here people. Bankruptcy means nothing here thanks to the withdrawal. I do believe they hinted at something there. What do I know. I will still assume that no liquidity at least until end of next year. So keep trading the highs and lows.. keep sweeping all that money under your carpets. And don’t forget to stuff it in your mattresses. Cuckoo Penny

Maybe folk they just decide to delist and deregister. Wouldn’t that be fascinating. Maybe they just roll up into something bigger and better. Recap is something very special. I’m beginning to enjoy the process. It takes time to warm up to it. But after a while it begins to feel amazing. It’s a crazy process. Supposedly lots of Pharmaceuticals do this hub and spoke thang. Wait for it…………. It’s anyone’s guess what happens next. Cuckoo Penny

All we know is that no liquidity until late next year. So keep playing the lows and highs. Stay you. Taco Taco

3.9 million shares remain and Naya wholly owned subsidiary now owning 80%. That Florida defunct drug seller ( bitch fund manager ) got a pretty sweet deal eh guys. Will they get some financing? What is he selling into? Stay tuned folk. Love watching cartoons. They’re Grrrreat! Cuckoo Penny

So nice that they are protecting investors. Smooth criminals. Good times for all the traders that kept their ownership and kept adding. This is great news. Stay strong. Stay you. Choo Choo. Crazy K

For you good folk.

https://s3.amazonaws.com/sec.irpass.cc/2386/0001493152-24-041913.pdf

Yes. They are definitely moving onwards Lime Time. What’s good for the goose is good for me. Who knows where this goes. Sadly I don’t get anything until end of 2025. I have to wait till BK or change of control. I’m leaning BK. Let’s hope they keep up the momentum till then. I would like to see you do well here. I wouldn’t trust this two tier management for all the tea in China. Shum is just a puppet fund boy that has zero control. Same goes for fish lips Teper. Both are fund managers with zero control. I look forward to the next merger or spin out. They have no money and they are just building leverage. Let’s hope for a BK. Hilarious. Enjoy the show. Stay you.

INVO to NAYA, 10/22/2024

Well it looks like I did read the collab agreement. I must have forgotten that I did. Any ways. Lots to it. Pretty standard. Well we have our deadline and we have a few more mergers to go. Eventually we will get to 2028. Patience is key. All is well until then. 15 years it will be for me maybe longer for others. Such is life. I doubt they will push it out further. Let’s cross those fingers. I won’t follow now that my mind is wrapped around deal and things are very clear. Bankruptcy liquidation will be pushed out which is perfectly ok with creditors and the lawyers. This makes everything come together on my end. I should’ve looked up the collaboration again, it really ties everything together. Look at it as one presidential term. Four more years to go. Be well. Stay you. Choo Choo Cuckoo Kenny

I see them requesting special privilege for ESHA. I see them not doing any definitive agreement until May / June. This would line up well the one year waiting period.

The great thing here people is that us Longs now know that nothing will be seen for a year. So there is no rush to do whatever you are planning for the remainder of the year. Sure makes my life easier. Nothing to think about now for 301 days. Enjoy. Crazy K

No conversion for c-2 shares until 210 days post merger. Or shall I say 301 days till anything. But we all know it’s when Sharon Barr decides what’s next. Go Astra Go!

Now add these 91 days to the 210 days for legacy shareholders. Forgot to add these days. So 301 days total which gets us closer to the 12 month mark. Enjoy.
“Commencing on the ninety-first (91st) day after the first issuance of any Series C-2 Preferred, the holders of Series C-2 Preferred shall be entitled to receive dividends on the stated value at the rate of ten percent (10%) per annum, payable in shares of the Company’s common stock, with each payment of a dividend payable in shares of the Company’s common stock at a conversion price of eighty-five percent (85%) of the average of the volume weighted average price of the Company’s common stock for the five (5) trading days before the applicable dividend date.“

Roll up!!!

Hilarious. Here it comes….. I just laugh. I hope you traders are doing your homework and reading latest filing.

“The Company also agreed to retain an investment banker to pursue a financing or a sale if it fails to meet certain liquidity covenants”

At least in my mind it is. All opinions and predictions. I know no one and nor would I want to know any of these scum bags. They are simply a means to an end for me. Pathetic bunch of people. Feel bad for the people that are getting robbed.

And I wouldn’t even believe that bullshit. Trust me when I say, these guys have zero desire to do anything here. Roll up is the strategy. Fertility is out the window. This is about building my shares. Cheers

As I said in last post….8k was just released pertaining to latest merger.

“The Series C-2 Preferred is only redeemable upon a “Bankruptcy Triggering Event” or a “Change of Control” that occurs 210 days after the closing date of the Merger.”

Each fund manager attached to each company ( fund ) has zero attachment. This is simply a roll up that’s being done at a snail pace. The incompetent US Trustee that’s managing the BK chapter 7 case for Immune pharmaceuticals and is taking his time liquidating the assets. It’s taken 2 years to just sell $12000 worth of assets. Now he claims that there could be even more assets. He doesn’t know for sure. lol. What a dope. The main legal group has now signed off on all liability In a nice compromise that prevents the group from suing the Trustee and he’s also given OakPoint Partners remnant buyer power of attorney to represent debtors in likely future claims. I see some lawsuits coming people. Still have full admin and final decree to go. But that’s going to be a long drawn out process especially with lawsuits on their way.

So this guy is very happy. Each day is a blessing and I feel great. I clearly see the detachment from a the fund managers here. They are simply rolling up a series of businesses for Sharon Barr at Astra Zeneca.

Another thing, the value in Naya is not fertility. It’s BioXcell which is now 100% wholly owned subsidiary of the new Naya company, BioXCell has had hundreds of millions invested in its business and it is a very well run entity with a solid group of team players making it the top of its game. Do not be lost in this brick and mortar business strategy that they want you to believe is possible. It’s not possible and Astra Zeneca has no desire to own brick locations. You can also read in the sec filings that the founders of these facilities are covered through share ownership in Naya. They have all been comfortably compensated and should not care on a decisive separation in the future. It will be divested in a timely fashion. All just my opinion. I will not believe for one second that they will keep that component. They will do all this when they decide to terminate and delist. Or when they simply delist and deregister their shares in order to roll up into Cytovia who controls Naya Bioscience. That’s right folk. Cytovia controls Naya. I own 9 percent of Naya thanks to my ownership in Immune Pharmaceuticals that controls Cytovia Therapeutics.

Why would I be upset? What gave you that impression? That’s the furthest from the truth. I’m very excited and looking forward to my next win. I just enjoy sharing my thoughts on my post-it board. Patience is key here chatter. Enjoy your trading day. Have a good one!

You're upset

Go Fuck yourself Shum. I know you dirt bags shall keep deceiving us Naya Legacy shareholders like the two little bitch frauds you are. Maybe some are turning their heads, like dogs on leashes, but I see you all clear as day. You and Fishlips will continue sucking off the tits of your whore Astra Zeneca. Sharon Barr will keep giving handouts even though both of you remain impotent pricks. You can go suck on my exhaust pipe you bitch-ass wankers. All I do is win no matter what. Cuckoo K

Shum statement…….“We are confident that our expanded portfolio business model and combined assets have the potential to create significant value for both legacy and new shareholders,” Shum says in the statement.“

There is ZERO value in fertility banks or whatever the hell you are pushing with that brick and mortar shit. Wake up people. The business expansion weighs on each US state and their current laws. Maybe they bring over to Europe and Asia. Still dumbest concept for Pharma. You are talking about a small percentage customer base. Too small I would fire every last one of you just for entertaining that avenue. Pharma should only be wanting to push drugs and the gene and cell editing side of things. This venture to me is you building the cap table for me and other like minded folk. Big period. So keep up your bullshit games but you better change the channel soon cause this fertility game show is weak at best and is making me damn tired. Hurry the fuck up with ESHA, Satellos, Immunis etc. Get off of Sharon Barr, and focus on making us our money. And please shut the fuck up. Your breath stinks like shit. Hula Hula Cuckoo Penny

You Big Pimpin’ trading wannabes. What a joke. You all want a free ride. Nothing great is simple. Only long-suffering can lay on my beach. Stay you. Cuckoo Narcissist Degenerate Delusional Crazy K

Form 8-K regarding the Merger, which will include the Amended and Restated Merger Agreement as an exhibit thereto.

55 mil volume. Hilarious. Sucks that none of you are taking anything home. Working for the Man must suck. Little traders never learn anything. Hope the big shot traders know what they’re doing. Keep on shorting and doing what you do. I need my shares. Soon truth will arise and soon Longs will know what’s next. I predict termination without winding down and some dissolving. Or maybe they just keep this train rolling for a bit while they create another spoke for the hub. The goal of Cytovia is do a Hub and Spoke type bullshit strategy. Massimo and Teper, both idiots. Too bad for you INVO shareholders. Burnt big time. Sucks to be you. Bette flick next time. But great work little broker guys. Easy shorting for you guys. Plus you made the man a few bucks. I do appreciate getting your shares in the long run. Pays to be the 9 percent owner of the entire Zoo. Sucks to be the little keepers of each exhibit. Day in and day out managing each exhibit must be exhausting as I sit back and relax watching all of you fight over kibbles and bits. Choo Choo Cuckoo, Delusional, Crazy K

Go! Go! Little bots Go! Hilarious.

You’re next on the list Satellos. You will have your turn soon enough. I think may need to wait for ESHA. Who knows. All depends on what Astra’s time line is. Patience is key. Crazy K

Some folk got a double and even a triple on two million shares that aren’t their own. Most folk are brokers working for the Man. So keep up the good work. Keep building the table. I need all my shares. Thanks Cuckoo Degenerate Kenny

Means nothing to me. All is controlled and determined by the company that has the power. All will be terminated with out winding down and will be rolled up into Cytovia and finally Astra Zeneca who is directing everything. This is not a victory in any shape or form. Next is ESHA merger. Next is Satellos merger. Next is Immunis merger. Naya will possibly build itself privately and will merge with either of the companies above. Or Teper will create another controlled company that will merge with one of the companies above.

invo........................................https://stockcharts.com/h-sc/ui?s=invo&p=W&b=5&g=0&id=p86431144783

INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

Like I said. Steve Shum is a piece of shit fund manager. A glorified broker. “Steve also serves as Managing Principal of Core Fund Management, LP and the Fund Manager of Core Fund, LP” I fucking hate car salesmen. I don’t trust any of them. 90 percent of you folk are scum bags working for the Man. This deal proves that this guy is a scum bag that steals from good folk. Dumb as shit folk but still good folk. Firstly, you should always research the management profiles. This way you know the Devil you’re dealing with. Watch and learn.

Wonder if Phil E Wood has any workings with INVO Biosciece and Wood Violet Fertility Clinic LLC. Looks like he’s a shareholder involved in the Immune Bankruptcy case.

And don’t feel bad for fertility clinic folk when they get crushed out of business as planned. They are being well compensated in the background.

Post-Closing Additional Payment Adjustment. Section 2.3.2 of the Asset Purchase Agreement is hereby amended by adding the following language immediately after the last sentence in such section:
The Parties acknowledge and agree that any INVO Parent Stock received as an Additional Payment on any Additional Payment Date shall be adjusted for any stock splits and combinations effectuated in INVO Parent Stock on or after the date hereof as follows: if INVO Parent at any time on or after the date hereof (A) subdivides (by any stock split, stock dividend, stock combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of INVO Parent Stock into a greater number of shares, the amount of shares of INVO Parent Stock to be received as an Additional Payment on any Additional Payment Date will be proportionately increased and (B) combines (by any stock split, stock dividend, stock combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of INVO Parent Stock into a smaller number of shares, the amount of shares of INVO Parent Stock to be received as an Additional Payment on any Additional Payment Date will be proportionately decreased. By way of example, if after the date hereof, INVO shall effectuate a 1-for-10 reverse stock split of the INVO Parent Stock whereby each ten (10) shares of INVO Parent Stock are converted into one (1) share of INVO Parent Stock, then the amount of shares of INVO Parent Stock issuable on any Additional Payment Date shall be proportionately reduced to reflect such
1-for-10 reverse stock split and accordingly the shares of INVO Parent Stock issuable on the first Additional Payment Date, the second Additional Payment Date and the third Additional Payment Date would be Eight Thousand (8,000) shares, Five Thousand Five Hundred (5,500) shares and Three Thousand Five Hundred (3,500) shares, respectively. This provision shall be applicable for the duration of the Term of the Asset Purchase Agreement.

Cellectis is now fully funded until 2026. Soon Cytovia will be as well. Maybe by December but I see them going for the extension once the new program begins. They need to do something right. So 2025 will be fun to watch the market grow but it won’t be providing any liquidity for Longs. Cheap capital is good. Yum yum.

Ya, the IPO market is stunted. Nothing really happening. I’ve been reading that it looks like 2025 we’ll see the IPO market normalizing. I doubt we’ll see anything from our group next year. Funny how SPACs have seen continued action. I think new 6 month extension for ESHA will really help them out. With the election happening, I doubt anything will happen for most companies. I think a lot of folk are shelving their IPOs for good reason. Way too much risk out there. Nothing really performing well. As I said in the past, I see a big reshuffling happening in the future. I call it a dismantling of the system. Or a big bust as some would call it. I’m hoping for some of my IPO’s to have a lacklustre performance. Especially where my shares are being kept. The lower the better.

Now that INVO has that funding from that Standard Merchant Cash Advance Agreement. I believe they should have enough funding to last six months which would delay this deal to March 2025. Very interesting.

Let’s also not forget the ESHA SPAC finance vehicle which has 116 million that will also be used to finance Cytovia well into 2026. Still many mergers ahead. The SPAC deal won’t occur until after Christmas and now with new possible 42 month allowance coming, I see that as well being pushed out to May / June at the latest. They still could do it in December but we all know that it may be asking a lot to get that arranged. Either way, 12 months of measurement takes us into end of 2025 and into first half of 2026.

I think many could continue to trade this right to delisting. The next recap in my head is Satellos Bioscience. I could see that rolling into Naya or Cytovia or maybe another controlled Sub. I hear through the grapevine that maybe there may even be another merger coming with Immunis. It would make sense since it’s flashing a trademark of Immune Pharmaceuticals which is Parent of Cytovia Therapeutics which controls the Naya Bioscience Sub. To be continued……

Astra Zeneca has a collaboration with Cellectis and Cytovia Tx which is controlling Naya. Astra Zeneca also owns 44 percent of Cellectis and has acquired Immune pharmaceuticals ( parent of Cytovia. therapeutics ) . So lots of connections here.

Maybe they are involved in a larger collaboration. I think it’s a roll up as Astra Zeneca as the final
Acquirer of all.

I see this merger between INVO and Naya Bioscience ( controlled sub of Cytovia Therapeutics as another Recapitalization.

Hi Folk. Looks like INVO may not meet the October deadline. Even if they do, I believe this company will terminate, delist and deregister their shares.

INVO.........................https://stockcharts.com/h-sc/ui?s=INVO&p=W&b=5&g=0&id=p86431144783

Looking good last couple days$$$ something cooking$$$ good luck y’all